Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux

ABSTRACT Purpose The aim of this study was to investigate the urinary concentration of epidermal growth factor (EGF) and monocyte chemotactic protein-1 (MCP-1) as reflux nephropathy (RN) biomarkers before and after endoscopic treatment of moderate to severe vesico-ureteral reflux (VUR). Materials...

Full description

Bibliographic Details
Main Authors: Valentina Pastore, Fabio Bartoli
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300549&lng=en&tlng=en
id doaj-ba90a43661e34255a3332ab6ac9f41e7
record_format Article
spelling doaj-ba90a43661e34255a3332ab6ac9f41e72020-11-25T01:03:28ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-611943354955510.1590/s1677-5538.ibju.2015.0132S1677-55382017000300549Urinary excretion of EGF and MCP-1 in children with vesico-ureteral refluxValentina PastoreFabio BartoliABSTRACT Purpose The aim of this study was to investigate the urinary concentration of epidermal growth factor (EGF) and monocyte chemotactic protein-1 (MCP-1) as reflux nephropathy (RN) biomarkers before and after endoscopic treatment of moderate to severe vesico-ureteral reflux (VUR). Materials and methods A prospective study was carried out on 72 children with moderate to severe VUR. All patients underwent endoscopic treatment using Macroplastique® or Deflux®. Vesico-ureteral reflux resolution was tested by post-operative voiding cystourethrography after 3 months and 2 years. Follow-up urinary samples were collected at that time. Control samples were taken from healthy children with no clinical evidence of renal and bladder disease and no history of UTI. Results In VUR patients, pre-operative urinary EGF levels had a down-regulation when compared to controls. Following successful VUR repair, urinary EGF levels of VUR children progressively increased only at long term follow-up but without returning to normal levels. Urinary MCP-1 levels were highly expressed in pre-operative samples and decreased markedly during early post-operative measurements. Urinary MCP-1 levels did not further decreased in late post-operative follow-up. In fact, these levels remained significantly higher when compared to controls. Conclusions Urinary levels of EGF and MCP-1 may become useful markers for monitoring the response to surgical treatment in VUR patients. Although endoscopic VUR treatment is effective in reducing the inflammatory response, the persistence of significant abnormal levels of inflammatory cytokines (such as urinary MCP-1) at long term follow-up suggests that surgery alone may not completely treat the chronic renal inflammation evidenced in these children.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300549&lng=en&tlng=enUrinary TractEGF Family of ProteinsVesico-Ureteral Reflux
collection DOAJ
language English
format Article
sources DOAJ
author Valentina Pastore
Fabio Bartoli
spellingShingle Valentina Pastore
Fabio Bartoli
Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
International Brazilian Journal of Urology
Urinary Tract
EGF Family of Proteins
Vesico-Ureteral Reflux
author_facet Valentina Pastore
Fabio Bartoli
author_sort Valentina Pastore
title Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
title_short Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
title_full Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
title_fullStr Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
title_full_unstemmed Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
title_sort urinary excretion of egf and mcp-1 in children with vesico-ureteral reflux
publisher Sociedade Brasileira de Urologia
series International Brazilian Journal of Urology
issn 1677-6119
description ABSTRACT Purpose The aim of this study was to investigate the urinary concentration of epidermal growth factor (EGF) and monocyte chemotactic protein-1 (MCP-1) as reflux nephropathy (RN) biomarkers before and after endoscopic treatment of moderate to severe vesico-ureteral reflux (VUR). Materials and methods A prospective study was carried out on 72 children with moderate to severe VUR. All patients underwent endoscopic treatment using Macroplastique® or Deflux®. Vesico-ureteral reflux resolution was tested by post-operative voiding cystourethrography after 3 months and 2 years. Follow-up urinary samples were collected at that time. Control samples were taken from healthy children with no clinical evidence of renal and bladder disease and no history of UTI. Results In VUR patients, pre-operative urinary EGF levels had a down-regulation when compared to controls. Following successful VUR repair, urinary EGF levels of VUR children progressively increased only at long term follow-up but without returning to normal levels. Urinary MCP-1 levels were highly expressed in pre-operative samples and decreased markedly during early post-operative measurements. Urinary MCP-1 levels did not further decreased in late post-operative follow-up. In fact, these levels remained significantly higher when compared to controls. Conclusions Urinary levels of EGF and MCP-1 may become useful markers for monitoring the response to surgical treatment in VUR patients. Although endoscopic VUR treatment is effective in reducing the inflammatory response, the persistence of significant abnormal levels of inflammatory cytokines (such as urinary MCP-1) at long term follow-up suggests that surgery alone may not completely treat the chronic renal inflammation evidenced in these children.
topic Urinary Tract
EGF Family of Proteins
Vesico-Ureteral Reflux
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300549&lng=en&tlng=en
work_keys_str_mv AT valentinapastore urinaryexcretionofegfandmcp1inchildrenwithvesicoureteralreflux
AT fabiobartoli urinaryexcretionofegfandmcp1inchildrenwithvesicoureteralreflux
_version_ 1725201167219163136